BioSpace News Archive

Workplace issues can arise anytime so it is always better to be prepared to seek out the problems directly in a mannered way to avoid any kind of personal rivalry.

Intergalactic Therapeutics closed on a Series A funding round worth $75 million. The company was launched by Advanced Technology Products Corporation (ATP).

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

Funding in the life sciences has been running rampant so far this year, with billions of dollars being funneled to companies from investors.

Relaunched due to popular demand, the AirPhysio is a drug-free breathing device that can be safely used by people of all ages.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced that it will host a key opinion leader webinar on cisplatin-induced ototoxicity on Thursday, October 28, 2021 at 10:00am EST/4:00pm CET.

Evox Therapeutics Ltd, a leading exosome therapeutics company, announces that it has, in close collaboration with one of its co-founder’s lab at the Karolinska Institute, published a landmark paper in Nature Biomedical Engineering outlining the engineering of exosomes for surface display of proteins.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50 µg dose level.

The pneumatic tourniquet market is anticipated to observe extensive growth opportunities during the forecast period of 2020-2030.

Growing support from the worldwide government bodies for the implementation of healthcare information technology is projected to work as one of the key drivers for the expansion of the global healthcare EDI market throughout the forecast period 2020–2030.